ALZN · Alzamend Neuro, Inc. · Proposed Sales
$1.17
-0.08 (-6.40%)
At close · Oct 22
Return incl. dividend (before tax)
Going-concern doubt
— flagged Sep 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors create substantial doubt about our ability to continue as a going concern for at least one year after the date that our condensed financial statements are issued.”View the 10-Q filed Sep 10, 2026
Market Cap
$5.69M
Shares
4.83M
Volume · Oct 22
14.26K
Avg daily vol (3M)
81K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.